1. Home
  2. WAT vs CHRW Comparison

WAT vs CHRW Comparison

Compare WAT & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • CHRW
  • Stock Information
  • Founded
  • WAT 1958
  • CHRW 1905
  • Country
  • WAT United States
  • CHRW United States
  • Employees
  • WAT N/A
  • CHRW N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • CHRW Oil Refining/Marketing
  • Sector
  • WAT Industrials
  • CHRW Consumer Discretionary
  • Exchange
  • WAT Nasdaq
  • CHRW Nasdaq
  • Market Cap
  • WAT 17.8B
  • CHRW 14.8B
  • IPO Year
  • WAT 1995
  • CHRW 1997
  • Fundamental
  • Price
  • WAT $295.50
  • CHRW $132.41
  • Analyst Decision
  • WAT Hold
  • CHRW Buy
  • Analyst Count
  • WAT 14
  • CHRW 20
  • Target Price
  • WAT $374.07
  • CHRW $115.74
  • AVG Volume (30 Days)
  • WAT 586.5K
  • CHRW 1.5M
  • Earning Date
  • WAT 10-31-2025
  • CHRW 10-29-2025
  • Dividend Yield
  • WAT N/A
  • CHRW 1.87%
  • EPS Growth
  • WAT 10.77
  • CHRW 58.22
  • EPS
  • WAT 11.09
  • CHRW 4.40
  • Revenue
  • WAT $3,046,056,000.00
  • CHRW $17,012,580,000.00
  • Revenue This Year
  • WAT $7.19
  • CHRW N/A
  • Revenue Next Year
  • WAT $6.40
  • CHRW $4.28
  • P/E Ratio
  • WAT $26.65
  • CHRW $30.11
  • Revenue Growth
  • WAT 5.89
  • CHRW N/A
  • 52 Week Low
  • WAT $275.05
  • CHRW $84.68
  • 52 Week High
  • WAT $423.56
  • CHRW $132.92
  • Technical
  • Relative Strength Index (RSI)
  • WAT 47.98
  • CHRW 75.67
  • Support Level
  • WAT $288.90
  • CHRW $125.12
  • Resistance Level
  • WAT $303.24
  • CHRW $129.39
  • Average True Range (ATR)
  • WAT 8.76
  • CHRW 2.45
  • MACD
  • WAT 0.63
  • CHRW -0.41
  • Stochastic Oscillator
  • WAT 37.96
  • CHRW 94.21

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About CHRW C.H. Robinson Worldwide Inc.

C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.

Share on Social Networks: